BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21813680)

  • 21. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
    Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition.
    Ishii K; Hosokawa C; Hyodo T; Sakaguchi K; Usami K; Shimamoto K; Hosono M; Yamazoe Y; Murakami T
    Ann Nucl Med; 2015 Jan; 29(1):78-83. PubMed ID: 25270712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
    Bunai T; Kakimoto A; Yoshikawa E; Terada T; Ouchi Y
    J Alzheimers Dis; 2019; 69(2):529-538. PubMed ID: 31104023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
    Wirth M; Madison CM; Rabinovici GD; Oh H; Landau SM; Jagust WJ
    J Neurosci; 2013 Mar; 33(13):5553-63. PubMed ID: 23536070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid-β load predicts medial temporal lobe dysfunction in Alzheimer dementia.
    Frings L; Spehl TS; Weber WA; Hüll M; Meyer PT
    J Nucl Med; 2013 Nov; 54(11):1909-14. PubMed ID: 24101684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability.
    Elman JA; Madison CM; Baker SL; Vogel JW; Marks SM; Crowley S; O'Neil JP; Jagust WJ
    Cereb Cortex; 2016 Feb; 26(2):695-707. PubMed ID: 25405944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the default mode network in aging and dementia based on molecular imaging.
    Ouchi Y; Kikuchi M
    Rev Neurosci; 2012 Feb; 23(3):263-8. PubMed ID: 22752783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.
    Jeon SY; Yi D; Byun MS; Choi HJ; Kim HJ; Lee JH; Baek H; Choe YM; Lee Y; Woo JI; Lee DY
    Neurosci Lett; 2016 Oct; 632():104-8. PubMed ID: 27574728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K
    Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal patterns of β-amyloid deposition in nondemented older adults.
    Sojkova J; Zhou Y; An Y; Kraut MA; Ferrucci L; Wong DF; Resnick SM
    Arch Neurol; 2011 May; 68(5):644-9. PubMed ID: 21555640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects.
    Lim HK; Nebes R; Snitz B; Cohen A; Mathis C; Price J; Weissfeld L; Klunk W; Aizenstein HJ
    Brain; 2014 Dec; 137(Pt 12):3327-38. PubMed ID: 25266592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks.
    Grothe MJ; Teipel SJ;
    Hum Brain Mapp; 2016 Jan; 37(1):35-53. PubMed ID: 26441321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-β load in aged APPPS1-21 mice.
    Waldron AM; Wintmolders C; Bottelbergs A; Kelley JB; Schmidt ME; Stroobants S; Langlois X; Staelens S
    Alzheimers Res Ther; 2015 Dec; 7(1):76. PubMed ID: 26666747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Amyloid Deposition Is Associated with Decreased Right Prefrontal Activation during Task Switching among Cognitively Normal Elderly.
    Oh H; Steffener J; Razlighi QR; Habeck C; Stern Y
    J Neurosci; 2016 Feb; 36(6):1962-70. PubMed ID: 26865619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve.
    Yoshizawa H; Gazes Y; Stern Y; Miyata Y; Uchiyama S
    Psychiatry Res; 2014 Jan; 221(1):78-85. PubMed ID: 24262800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
    Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G
    Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain Glucose Metabolism in Cerebral Amyloid Angiopathy: An FDG-PET Study.
    Bergeret S; Queneau M; Rodallec M; Landeau B; Chetelat G; Hong YT; Dumurgier J; Hugon J; Paquet C; Farid K; Baron JC
    Stroke; 2021 Apr; 52(4):1478-1482. PubMed ID: 33611942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.